One RSV shot cuts severe lung infections in older adults for three seasons, trial shows
A phase 3 trial involving nearly 25,000 older adults across 17 countries found that a single dose of the RSVPreF3 OA vaccine reduced RSV-related lower respiratory tract disease by 63%…